PTEN and non-small cell lung carcinoma: To further confirm our findings, we assessed miR-21 expression levels using ISH assays (Fig. 2D) and Pten expression levels by IHC on paraffin embedded samples from 46 NSCLC patients treated with TKI(gefitinib or erlotinib) as treatment and followed up their clinical response and survival status (Table S2).